Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 103Carcinoma, Renal Cell 30Urinary Bladder Neoplasms 22Breast Neoplasms 20Carcinoma, Transitional Cell 11Lung Neoplasms 10Melanoma 9Neoplasms 8Kidney Neoplasms 8Neoplasm Metastasis 7Colonic Neoplasms 7Sarcoma 6Pancreatic Neoplasms 6Ovarian Neoplasms 6Metastatic Castration-resistant Prostate Cancer 6Head and Neck Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Uterine Cervical Neoplasms 4Stomach Neoplasms 4Brain Neoplasms 4Osteosarcoma 3Diabetes Mellitus 3Colorectal Neoplasms 3Carcinoma, Squamous Cell 3Carcinoma, Hepatocellular 3Urologic Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Rectal Neoplasms 2Prostatic Hyperplasia 2

Interventions

Deamino Arginine Vasopressin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Castrate Resistance Prostate Cancer × Genitourinary × Clear all
NCT04113005 2019-10-02

Safety and Tolerability Analysis of Combining Desmopressin With Docetaxel for the Treatment of Castration-Resistant Prostate Cancer

Sunnybrook Health Sciences Centre

Phase EARLY_PHASE1 Unknown
10 enrolled
Genitourinary

Castrate Resistance Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡